Imunon, Inc. (IMNN)

↓ Download CSV

CIK 0000749647 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

Key ratios (FY2025)

-205.3%
Return on equity
Metric (FY)2025202420232022202120202019201820172016
Revenue$500.0K$500.0K$500.0K$500.0K$500.0K$500.0K
Operating Income-$14.65M-$19.13M-$21.03M-$24.92M-$21.01M-$18.49M-$20.57M-$21.07M-$18.47M-$20.65M
Net Income-$14.50M-$18.62M-$19.51M-$35.90M-$20.77M-$21.48M-$16.85M-$11.88M-$20.40M-$22.05M
EPS (Diluted)$-6.83$-16.94$-2.16$-5.03$-3.83
Total Assets$12.29M$9.72M$21.92M$43.98M$74.05M$37.53M$38.28M$46.86M$47.51M$30.85M
Total Liabilities$5.23M$5.47M$8.53M$14.65M$18.25M$18.92M$23.72M$25.99M$20.81M$24.12M
Shareholders' Equity$7.06M$4.24M$13.39M$29.33M$55.80M$18.61M$14.56M$20.86M$26.70M$6.73M
Cash & Equivalents$8.78M$5.87M$5.84M$11.49M$19.59M$17.16M$6.88M$13.35M$11.44M$2.62M
Operating Cash Flow-$13.90M-$18.85M-$19.02M-$23.10M-$16.22M-$15.62M-$20.26M-$7.04M-$16.64M-$18.38M
Capital Expenditures$280.6K$29.5K$451.8K$267.8K$311.6K$19.1K$349.2K$138.4K$38.6K$62.5K
Shares Outstanding3.42M966.7K9.40M7.44M5.77M2.71M23.26M18.83M17.28M2.23M